STAAR Surgical | STAA - Operating Expenses


STAAR Surgical reported $76.12M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Bausch Health Companies USD 2.04B 42M Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Cooper Companies USD 1.11B 301.2M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Novartis USD 9.29B 507M Mar/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Orthofix International USD 213.79M 12.36M Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 76.12M 7.38M Mar/2026
Utah Medical Products USD 6.6M 354K Dec/2025